Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wildbiftek wildbiftek May 2, 2013 6:01 PM Flag

    Cabo and OS

    In light of today's panel rejection of Tivozanib rejection (thanks for the heads up Wilder), I think don't Cabo will find approval in mCRPC with just PFS and pain palliation. In light of this, management made a good move in starting up COMET-1 as soon as they could when they found out that they wouldn't be getting the SPA they requested. I think the upcoming ASCO briefing on Cabo's OS efficacy will be an important factor in determining my future position in this stock.

 
EXEL
8.64-0.07(-0.80%)4:00 PMEDT